Results 81 to 90 of about 4,653 (155)

Machine learning-based prediction model for drug target identification and MASH improvement: a comprehensive analysis of biochemical and ferroptosis/autophagy biomarkers. [PDF]

J Physiol Biochem
Matboli M, Elanwar A, Khaled R, Khaled A, Eltantawy EHB, Hamam GG, Ahmed MY, Fouad M, Tarek AA, Elmasry M, El-Shafei MM, Aboulhoda BE, Diab GI, Aboughaleb IH.   +13 more
europepmc   +1 more source

Clinical Impact of Febuxostat in HFpEF Versus HFrEF: Insights from a Prospective Cohort. [PDF]

Balkan Med J
Ahsaan F, Latif B, Rehman Z.
europepmc   +1 more source

A treat-to-target urate management strategy does not improve kidney outcome in patients with chronic kidney disease and asymptomatic hyperuricemia: a target trial emulation. [PDF]

Ann Med
Liu Q, Hu Y, He R, Fang Z, He W, Zheng D, Jin J, He Q.   +7 more
europepmc   +1 more source

Soluble uric acid suppresses neutrophil-mediated host defense in sepsis. [PDF]

Nat Commun
Li Q, Anders J, Flora K, Ehreiser L, Wendling C, Zhang F, Chang L, Zhao D, Li L, Vogl R, Soehnlein O, Steiger S.   +11 more
europepmc   +1 more source

Response to Febuxostat in Elderly Gout Patients with Clinical Subtypes of Hyperuricemia: A Prospective Cohort Study. [PDF]

J Inflamm Res
Li J, Hu S, Ma L, Di S, Yan F, Gong Y, Li K, Huang X, Xu Y, Wang Y, Chen Y.   +10 more
europepmc   +1 more source

Febuxostat Improves MASLD in Male Rats: Roles of XOR Inhibition and Associated JNK/NRF2/HO-1 Pathway Changes. [PDF]

Int J Mol Sci
Pu Z, Cen Y, Yang B, Xing K, Lian L, Chi X, Yang J, Zhang Y.   +7 more
europepmc   +1 more source

Formulation, characterization and evaluation of cytotoxic potential for febuxostat loaded chitosomes against cervical cancer cells (Hela cells). [PDF]

Sci Rep
Sakran W, Abdel-Hakim M, Abdel-Rashid RS.   +2 more
europepmc   +1 more source

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout. [PDF]

Arthritis Care Res (Hoboken)
Richette P, Walter-Petrich A, Nguyen QD, Resche-Rigon M, Nguyen QHD, Do MD, Mai TP, Nguyen TD, Perez-Ruiz F, Letavernier E, Pascart T, Latourte A, Ea HK, Bardin T.   +13 more
europepmc   +1 more source

Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort study. [PDF]

Arthritis Res Ther
Guo K, Li C, Terkeltaub R, Dalbeth N, Wang X, Ji X, Chen Y, Cui L, Liu Z, Li X, He Y, Lu J, Sun W, Han L, Zhang H, Ji A, Sun M, Wang C.   +17 more
europepmc   +1 more source

Hepatic Safety of Febuxostat and Allopurinol in Gout Patients: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Ther Clin Risk Manag
Dewi C, Puspita F, Insani WN, Sinuraya RK, Puspitasari IM, Zakiyah N.   +5 more
europepmc   +1 more source